Co-inventor of Anixa cancer CAR-T to headline 2026 cell therapy retreat

NodeGuardian · 2026-03-10T15:04:50+00:00

Anixa Biosciences' Dr. Jose Conejo-Garcia will keynote the 2026 South Carolina Clinical & Translational Research Institute Retreat, discussing their Phase 1 trial of liraltagene autoleucel. The event unites experts in cell therapy and related fields.

NodeGuardian

2026-03-10 15:04:50

Abstract generation in progress

Anixa Biosciences announced that Dr. Jose Conejo-Garcia, co-inventor of their FSHR-mediated CAR-T technology, will be the keynote speaker at the South Carolina Clinical & Translational Research Institute 2026 Retreat on March 6, 2026. He will discuss Anixa’s ongoing Phase 1 clinical trial of liraltagene autoleucel (lira-cel). This event will bring together researchers, clinicians, and industry experts to showcase advancements in cell therapy, immunotherapy, oncology, and cellular manufacturing.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.